Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Works matching IS 0741238X AND DT 2011 AND VI 28 AND IP 7
Results: 8
1
2
Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 555, doi. 10.1007/s12325-011-0035-z
- By:
- Publication type:
- Article
3
Erratum to: CREON (Pancrelipase delayed-release capsules) for the treatment of exocrine pancreatic insufficiency.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
4
Pseudobulbar affect: an under-recognized and under-treated neurological disorder.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 586, doi. 10.1007/s12325-011-0031-3
- By:
- Publication type:
- Article
5
Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 566, doi. 10.1007/s12325-011-0037-x
- By:
- Publication type:
- Article
6
Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 521, doi. 10.1007/s12325-011-0036-y
- By:
- Publication type:
- Article
7
Rituximab in chronic lymphocytic leukemia.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 534, doi. 10.1007/s12325-011-0032-2
- By:
- Publication type:
- Article
8
Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 7, p. 575, doi. 10.1007/s12325-011-0038-9
- By:
- Publication type:
- Article